Combined hormonal contraceptive basically made by a combination of an estrogen and a progestogen which are primarily used to prevent unwanted pregnancies. Combined hormonal contraceptives are one of the effective contraceptives in modern medicine. Since late 1950s variety of innovation has been developed to improve the efficacy and safety of combined hormonal contraceptive. The trends have been shifted towards less androgenic progestogens and lower doses of estrogen and progestogen. Changing in drug doses and modification in drug component with the incorporation of new technologies that can reduce the risk factor and the continuing development of novel delivery systems that can be helpful to fulfill unmet needs of the market. The other health benefits of combined hormonal contraceptives include they reduce the risk of iron deficiency anemia, endometriosis, used in treating acne vulgaris, irregular menstrual flow, and polycystic ovarian syndrome. The mechanism of combined hormonal contraceptive is inhibition of follicle stimulating hormone and luteinizing hormone. Ethinylestradiol is the most common estrogen used in combined hormonal contraceptives, whereas other hormones are also used. The combined hormonal contraceptive products are available in various forms whereas pills have the maximum share in the combined hormonal contraceptive market. According to the Association of Women Health, around 100 million women use combined hormonal contraceptives throughout the world.
The growth of the combined hormonal contraceptive market is driven by growing predominance and more productive medications with emerging interest in quick substitutes. Reduction in the cost of hospitalization and high efficacy can be the prime driving factors for the growth of the combined hormonal contraceptive market over the forecast period. In emerging countries, the adoption of combined hormonal contraceptives has increased, along with increasing health consciousness and awareness. Growing menstruating population worldwide and various initiatives taken by the governments, such as birth control and women health awareness programs, are factors expected to increase the usage of combined hormonal contraceptive products globally. Strategic collaborations and acquisitions among manufacturers are also expected to boost the growth of the combined hormonal contraceptive market. However, side effects related to the combined hormonal contraceptive products can hamper the growth of the combined hormonal contraceptive market.
The global Combined hormonal contraceptive market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Combined hormonal contraceptive volume and value at global level, regional level and company level. From a global perspective, this report represents overall Combined hormonal contraceptive market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Combined hormonal contraceptive in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Combined hormonal contraceptive manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Teva Pharmaceutical Industries
Bayer HealthCare Pharmaceuticals
Actavis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Watson Pharma
Cipla
Novartis International
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Pills
Patch
Ring
Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-commerce
Others
The growth of the combined hormonal contraceptive market is driven by growing predominance and more productive medications with emerging interest in quick substitutes. Reduction in the cost of hospitalization and high efficacy can be the prime driving factors for the growth of the combined hormonal contraceptive market over the forecast period. In emerging countries, the adoption of combined hormonal contraceptives has increased, along with increasing health consciousness and awareness. Growing menstruating population worldwide and various initiatives taken by the governments, such as birth control and women health awareness programs, are factors expected to increase the usage of combined hormonal contraceptive products globally. Strategic collaborations and acquisitions among manufacturers are also expected to boost the growth of the combined hormonal contraceptive market. However, side effects related to the combined hormonal contraceptive products can hamper the growth of the combined hormonal contraceptive market.
The global Combined hormonal contraceptive market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Combined hormonal contraceptive volume and value at global level, regional level and company level. From a global perspective, this report represents overall Combined hormonal contraceptive market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Combined hormonal contraceptive in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Combined hormonal contraceptive manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Teva Pharmaceutical Industries
Bayer HealthCare Pharmaceuticals
Actavis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Watson Pharma
Cipla
Novartis International
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Pills
Patch
Ring
Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-commerce
Others
Table of Contents
Executive Summary
1 Industry Overview of Combined hormonal contraceptive
1.1 Definition of Combined hormonal contraceptive
1.2 Combined hormonal contraceptive Segment by Type
1.2.1 Global Combined hormonal contraceptive Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Pills
1.2.3 Patch
1.2.4 Ring
1.3 Combined hormonal contraceptive Segment by Applications
1.3.1 Global Combined hormonal contraceptive Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-commerce
1.3.5 Others
1.4 Global Combined hormonal contraceptive Overall Market
1.4.1 Global Combined hormonal contraceptive Revenue (2014-2025)
1.4.2 Global Combined hormonal contraceptive Production (2014-2025)
1.4.3 North America Combined hormonal contraceptive Status and Prospect (2014-2025)
1.4.4 Europe Combined hormonal contraceptive Status and Prospect (2014-2025)
1.4.5 China Combined hormonal contraceptive Status and Prospect (2014-2025)
1.4.6 Japan Combined hormonal contraceptive Status and Prospect (2014-2025)
1.4.7 Southeast Asia Combined hormonal contraceptive Status and Prospect (2014-2025)
1.4.8 India Combined hormonal contraceptive Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Combined hormonal contraceptive
2.3 Manufacturing Process Analysis of Combined hormonal contraceptive
2.4 Industry Chain Structure of Combined hormonal contraceptive
3 Development and Manufacturing Plants Analysis of Combined hormonal contraceptive
3.1 Capacity and Commercial Production Date
3.2 Global Combined hormonal contraceptive Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Combined hormonal contraceptive
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Combined hormonal contraceptive Production and Capacity Analysis
4.2 Combined hormonal contraceptive Revenue Analysis
4.3 Combined hormonal contraceptive Price Analysis
4.4 Market Concentration Degree
5 Combined hormonal contraceptive Regional Market Analysis
5.1 Combined hormonal contraceptive Production by Regions
5.1.1 Global Combined hormonal contraceptive Production by Regions
5.1.2 Global Combined hormonal contraceptive Revenue by Regions
5.2 Combined hormonal contraceptive Consumption by Regions
5.3 North America Combined hormonal contraceptive Market Analysis
5.3.1 North America Combined hormonal contraceptive Production
5.3.2 North America Combined hormonal contraceptive Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Combined hormonal contraceptive Import and Export
5.4 Europe Combined hormonal contraceptive Market Analysis
5.4.1 Europe Combined hormonal contraceptive Production
5.4.2 Europe Combined hormonal contraceptive Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Combined hormonal contraceptive Import and Export
5.5 China Combined hormonal contraceptive Market Analysis
5.5.1 China Combined hormonal contraceptive Production
5.5.2 China Combined hormonal contraceptive Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Combined hormonal contraceptive Import and Export
5.6 Japan Combined hormonal contraceptive Market Analysis
5.6.1 Japan Combined hormonal contraceptive Production
5.6.2 Japan Combined hormonal contraceptive Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Combined hormonal contraceptive Import and Export
5.7 Southeast Asia Combined hormonal contraceptive Market Analysis
5.7.1 Southeast Asia Combined hormonal contraceptive Production
5.7.2 Southeast Asia Combined hormonal contraceptive Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Combined hormonal contraceptive Import and Export
5.8 India Combined hormonal contraceptive Market Analysis
5.8.1 India Combined hormonal contraceptive Production
5.8.2 India Combined hormonal contraceptive Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Combined hormonal contraceptive Import and Export
6 Combined hormonal contraceptive Segment Market Analysis (by Type)
6.1 Global Combined hormonal contraceptive Production by Type
6.2 Global Combined hormonal contraceptive Revenue by Type
6.3 Combined hormonal contraceptive Price by Type
7 Combined hormonal contraceptive Segment Market Analysis (by Application)
7.1 Global Combined hormonal contraceptive Consumption by Application
7.2 Global Combined hormonal contraceptive Consumption Market Share by Application (2014-2019)
8 Combined hormonal contraceptive Major Manufacturers Analysis
8.1 Teva Pharmaceutical Industries
8.1.1 Teva Pharmaceutical Industries Combined hormonal contraceptive Production Sites and Area Served
8.1.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
8.1.3 Teva Pharmaceutical Industries Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bayer HealthCare Pharmaceuticals
8.2.1 Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Production Sites and Area Served
8.2.2 Bayer HealthCare Pharmaceuticals Product Introduction, Application and Specification
8.2.3 Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Actavis
8.3.1 Actavis Combined hormonal contraceptive Production Sites and Area Served
8.3.2 Actavis Product Introduction, Application and Specification
8.3.3 Actavis Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Pfizer
8.4.1 Pfizer Combined hormonal contraceptive Production Sites and Area Served
8.4.2 Pfizer Product Introduction, Application and Specification
8.4.3 Pfizer Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Combined hormonal contraceptive Production Sites and Area Served
8.5.2 Johnson & Johnson Product Introduction, Application and Specification
8.5.3 Johnson & Johnson Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 GlaxoSmithKline
8.6.1 GlaxoSmithKline Combined hormonal contraceptive Production Sites and Area Served
8.6.2 GlaxoSmithKline Product Introduction, Application and Specification
8.6.3 GlaxoSmithKline Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Watson Pharma
8.7.1 Watson Pharma Combined hormonal contraceptive Production Sites and Area Served
8.7.2 Watson Pharma Product Introduction, Application and Specification
8.7.3 Watson Pharma Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Cipla
8.8.1 Cipla Combined hormonal contraceptive Production Sites and Area Served
8.8.2 Cipla Product Introduction, Application and Specification
8.8.3 Cipla Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Novartis International
8.9.1 Novartis International Combined hormonal contraceptive Production Sites and Area Served
8.9.2 Novartis International Product Introduction, Application and Specification
8.9.3 Novartis International Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Combined hormonal contraceptive Market
9.1 Global Combined hormonal contraceptive Market Trend Analysis
9.1.1 Global Combined hormonal contraceptive Market Size (Volume and Value) Forecast 2019-2025
9.2 Combined hormonal contraceptive Regional Market Trend
9.2.1 North America Combined hormonal contraceptive Forecast 2019-2025
9.2.2 Europe Combined hormonal contraceptive Forecast 2019-2025
9.2.3 China Combined hormonal contraceptive Forecast 2019-2025
9.2.4 Japan Combined hormonal contraceptive Forecast 2019-2025
9.2.5 Southeast Asia Combined hormonal contraceptive Forecast 2019-2025
9.2.6 India Combined hormonal contraceptive Forecast 2019-2025
9.3 Combined hormonal contraceptive Market Trend (Product Type)
9.4 Combined hormonal contraceptive Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Combined hormonal contraceptive Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Executive Summary
1 Industry Overview of Combined hormonal contraceptive
1.1 Definition of Combined hormonal contraceptive
1.2 Combined hormonal contraceptive Segment by Type
1.2.1 Global Combined hormonal contraceptive Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Pills
1.2.3 Patch
1.2.4 Ring
1.3 Combined hormonal contraceptive Segment by Applications
1.3.1 Global Combined hormonal contraceptive Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-commerce
1.3.5 Others
1.4 Global Combined hormonal contraceptive Overall Market
1.4.1 Global Combined hormonal contraceptive Revenue (2014-2025)
1.4.2 Global Combined hormonal contraceptive Production (2014-2025)
1.4.3 North America Combined hormonal contraceptive Status and Prospect (2014-2025)
1.4.4 Europe Combined hormonal contraceptive Status and Prospect (2014-2025)
1.4.5 China Combined hormonal contraceptive Status and Prospect (2014-2025)
1.4.6 Japan Combined hormonal contraceptive Status and Prospect (2014-2025)
1.4.7 Southeast Asia Combined hormonal contraceptive Status and Prospect (2014-2025)
1.4.8 India Combined hormonal contraceptive Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Combined hormonal contraceptive
2.3 Manufacturing Process Analysis of Combined hormonal contraceptive
2.4 Industry Chain Structure of Combined hormonal contraceptive
3 Development and Manufacturing Plants Analysis of Combined hormonal contraceptive
3.1 Capacity and Commercial Production Date
3.2 Global Combined hormonal contraceptive Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Combined hormonal contraceptive
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Combined hormonal contraceptive Production and Capacity Analysis
4.2 Combined hormonal contraceptive Revenue Analysis
4.3 Combined hormonal contraceptive Price Analysis
4.4 Market Concentration Degree
5 Combined hormonal contraceptive Regional Market Analysis
5.1 Combined hormonal contraceptive Production by Regions
5.1.1 Global Combined hormonal contraceptive Production by Regions
5.1.2 Global Combined hormonal contraceptive Revenue by Regions
5.2 Combined hormonal contraceptive Consumption by Regions
5.3 North America Combined hormonal contraceptive Market Analysis
5.3.1 North America Combined hormonal contraceptive Production
5.3.2 North America Combined hormonal contraceptive Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Combined hormonal contraceptive Import and Export
5.4 Europe Combined hormonal contraceptive Market Analysis
5.4.1 Europe Combined hormonal contraceptive Production
5.4.2 Europe Combined hormonal contraceptive Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Combined hormonal contraceptive Import and Export
5.5 China Combined hormonal contraceptive Market Analysis
5.5.1 China Combined hormonal contraceptive Production
5.5.2 China Combined hormonal contraceptive Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Combined hormonal contraceptive Import and Export
5.6 Japan Combined hormonal contraceptive Market Analysis
5.6.1 Japan Combined hormonal contraceptive Production
5.6.2 Japan Combined hormonal contraceptive Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Combined hormonal contraceptive Import and Export
5.7 Southeast Asia Combined hormonal contraceptive Market Analysis
5.7.1 Southeast Asia Combined hormonal contraceptive Production
5.7.2 Southeast Asia Combined hormonal contraceptive Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Combined hormonal contraceptive Import and Export
5.8 India Combined hormonal contraceptive Market Analysis
5.8.1 India Combined hormonal contraceptive Production
5.8.2 India Combined hormonal contraceptive Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Combined hormonal contraceptive Import and Export
6 Combined hormonal contraceptive Segment Market Analysis (by Type)
6.1 Global Combined hormonal contraceptive Production by Type
6.2 Global Combined hormonal contraceptive Revenue by Type
6.3 Combined hormonal contraceptive Price by Type
7 Combined hormonal contraceptive Segment Market Analysis (by Application)
7.1 Global Combined hormonal contraceptive Consumption by Application
7.2 Global Combined hormonal contraceptive Consumption Market Share by Application (2014-2019)
8 Combined hormonal contraceptive Major Manufacturers Analysis
8.1 Teva Pharmaceutical Industries
8.1.1 Teva Pharmaceutical Industries Combined hormonal contraceptive Production Sites and Area Served
8.1.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
8.1.3 Teva Pharmaceutical Industries Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bayer HealthCare Pharmaceuticals
8.2.1 Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Production Sites and Area Served
8.2.2 Bayer HealthCare Pharmaceuticals Product Introduction, Application and Specification
8.2.3 Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Actavis
8.3.1 Actavis Combined hormonal contraceptive Production Sites and Area Served
8.3.2 Actavis Product Introduction, Application and Specification
8.3.3 Actavis Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Pfizer
8.4.1 Pfizer Combined hormonal contraceptive Production Sites and Area Served
8.4.2 Pfizer Product Introduction, Application and Specification
8.4.3 Pfizer Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Combined hormonal contraceptive Production Sites and Area Served
8.5.2 Johnson & Johnson Product Introduction, Application and Specification
8.5.3 Johnson & Johnson Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 GlaxoSmithKline
8.6.1 GlaxoSmithKline Combined hormonal contraceptive Production Sites and Area Served
8.6.2 GlaxoSmithKline Product Introduction, Application and Specification
8.6.3 GlaxoSmithKline Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Watson Pharma
8.7.1 Watson Pharma Combined hormonal contraceptive Production Sites and Area Served
8.7.2 Watson Pharma Product Introduction, Application and Specification
8.7.3 Watson Pharma Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Cipla
8.8.1 Cipla Combined hormonal contraceptive Production Sites and Area Served
8.8.2 Cipla Product Introduction, Application and Specification
8.8.3 Cipla Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Novartis International
8.9.1 Novartis International Combined hormonal contraceptive Production Sites and Area Served
8.9.2 Novartis International Product Introduction, Application and Specification
8.9.3 Novartis International Combined hormonal contraceptive Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Combined hormonal contraceptive Market
9.1 Global Combined hormonal contraceptive Market Trend Analysis
9.1.1 Global Combined hormonal contraceptive Market Size (Volume and Value) Forecast 2019-2025
9.2 Combined hormonal contraceptive Regional Market Trend
9.2.1 North America Combined hormonal contraceptive Forecast 2019-2025
9.2.2 Europe Combined hormonal contraceptive Forecast 2019-2025
9.2.3 China Combined hormonal contraceptive Forecast 2019-2025
9.2.4 Japan Combined hormonal contraceptive Forecast 2019-2025
9.2.5 Southeast Asia Combined hormonal contraceptive Forecast 2019-2025
9.2.6 India Combined hormonal contraceptive Forecast 2019-2025
9.3 Combined hormonal contraceptive Market Trend (Product Type)
9.4 Combined hormonal contraceptive Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Combined hormonal contraceptive Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
